WSJ News Exclusive | Novo Nordisk to Slash Insulin Prices by Up to 75%

United States News News

WSJ News Exclusive | Novo Nordisk to Slash Insulin Prices by Up to 75%
United States Latest News,United States Headlines
  • 📰 WSJ
  • ⏱ Reading Time:
  • 18 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 63%

Breaking: Novo Nordisk, a large insulin maker, plans to cut the prices of its widely used products up to 75% to make them more affordable for patients. This follows a similar move by Eli Lilly.

The insulin maker is the latest to plan sharp price cuts for the diabetes treatments to make them more affordable

California Gov. Gavin Newsom said the state will begin making its own insulin to help lower the cost of the diabetes medication. WSJ explains how insulin got so expensive in the U.S. and explores whether a policy initiative like California’s could succeed in driving down costs. Photo Illustration: Ryan TrefesNovo Nordisk A/S is set to cut the U.S.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

WSJ /  🏆 98. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Disability rights leader, Judy Heumann, dies at 75Disability rights leader, Judy Heumann, dies at 75Judy Heumann, the brave woman who was denied a teaching position because she was in a wheelchair and turned the rejection into a lifetime of disability activism that changed the world, has died at 75. Sunday TODAY’s Willie Geist remembers a life well-lived.
Read more »

SVB collapse: Markets start pricing in Fed rate cuts of 75 basis pointsMarkets have started pricing in Fed rate cuts of 75 basis points by the year's end as SVB's collapse creates panic about other banks
Read more »

Stem cell–derived heart cells injected into first patientStem cell–derived heart cells injected into first patientNature Medicine explores the latest translational and clinical research news, with Heartseed and Novo Nordisk’s clinical trial of iPSC–derived cardiomyocytes for the treatment of heart failure.
Read more »

WSJ News Exclusive | China Plans New Middle East Summit as Diplomatic Role Takes ShapeWSJ News Exclusive | China Plans New Middle East Summit as Diplomatic Role Takes ShapeThe Saudi-Iran deal, hashed out behind closed doors in Beijing last week, takes on some of the most sensitive issues between two countries that have been on opposite sides of proxy conflicts across the Middle East for years
Read more »

WSJ News Exclusive | Britain Bulks Up Military Spending to Counter Russia and ChinaWSJ News Exclusive | Britain Bulks Up Military Spending to Counter Russia and ChinaThe U.K. intends to reinforce its nuclear defenses and replenish its munitions stockpiles with an extra $6 billion in military spending
Read more »



Render Time: 2025-02-22 10:18:11